{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:03:21Z","timestamp":1792627401155,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1011948","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000}}],"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC2303300"],"award-info":[{"award-number":["2022YFC2303300"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC2305900"],"award-info":[{"award-number":["2023YFC2305900"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFF0702002"],"award-info":[{"award-number":["2021YFF0702002"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20336"],"award-info":[{"award-number":["U22A20336"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019537","name":"Science Fund for Distinguished Young Scholars of Hubei Province","doi-asserted-by":"publisher","award":["2021CFA050"],"award-info":[{"award-number":["2021CFA050"]}],"id":[{"id":"10.13039\/501100019537","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic Priority Research Program of the Chinese Academy of Sciences","award":["XDB049000"],"award-info":[{"award-number":["XDB049000"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Crimean-Congo hemorrhagic fever virus (CCHFV) is a highly pathogenic tick-borne virus, prevalent in more than 30 countries worldwide. Human infection by this virus leads to severe illness, with an average case fatality of 40%. There is currently no approved vaccine or drug to treat the disease. Neutralizing antibodies are a promising approach to treat virus infectious diseases. This study generated 37 mouse-derived specific monoclonal antibodies against CCHFV Gc subunit. Neutralization assays using pseudotyped virus and authentic CCHFV identified Gc8, Gc13, and Gc35 as neutralizing antibodies. Among them, Gc13 had the highest neutralizing activity and binding affinity with CCHFV Gc. Consistently, Gc13, but not Gc8 or Gc35, showed <jats:italic>in vivo<\/jats:italic> protective efficacy (62.5% survival rate) against CCHFV infection in a lethal mouse infection model. Further characterization studies suggested that Gc8 and Gc13 may recognize a similar, linear epitope in domain II of CCHFV Gc, while Gc35 may recognize a different epitope in Gc. Cryo-electron microscopy of Gc-Fab complexes indicated that both Gc8 and Gc13 bind to the conserved fusion loop region and Gc13 had stronger interactions with sGc-trimers. This was supported by the ability of Gc13 to block CCHFV GP-mediated membrane fusion. Overall, this study provides new therapeutic strategies to treat CCHF and new insights into the interaction between antibodies with CCHFV Gc proteins.<\/jats:p>","DOI":"10.1371\/journal.ppat.1011948","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T18:50:54Z","timestamp":1706813454000},"page":"e1011948","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean\u2013Congo hemorrhagic fever virus"],"prefix":"10.1371","volume":"20","author":[{"given":"Liushuai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibo","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-3530","authenticated-orcid":true,"given":"Manli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"ppat.1011948.ref001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"MS Mehand","year":"2018","journal-title":"Antiviral Res"},{"key":"ppat.1011948.ref002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2017.11.019","article-title":"Second International Conference on Crimean-Congo Hemorrhagic Fever","volume":"150","author":"JR Spengler","year":"2018","journal-title":"Antiviral Res"},{"key":"ppat.1011948.ref003","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/v8040106","article-title":"Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus.","volume":"8","author":"M Zivcec","year":"2016","journal-title":"Viruses"},{"key":"ppat.1011948.ref004","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/JVI.01859-09","article-title":"Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function","volume":"84","author":"E Bergeron","year":"2010","journal-title":"J Virol"},{"key":"ppat.1011948.ref005","doi-asserted-by":"crossref","first-page":"e2804","DOI":"10.1371\/journal.pntd.0002804","article-title":"Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever.","volume":"8","author":"L Oestereich","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ppat.1011948.ref006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2018.06.013","article-title":"Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice.","volume":"157","author":"DW Hawman","year":"2018","journal-title":"Antiviral Res"},{"key":"ppat.1011948.ref007","article-title":"Ribavirin for treating Crimean Congo haemorrhagic fever.","volume":"6","author":"S Johnson","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"ppat.1011948.ref008","doi-asserted-by":"crossref","first-page":"105273","DOI":"10.1016\/j.antiviral.2022.105273","article-title":"In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean\u2013Congo hemorrhagic fever virus","volume":"199","author":"Q Wang","year":"2022","journal-title":"Antiviral Res"},{"key":"ppat.1011948.ref009","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/infdis\/jiy163","article-title":"Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection.","volume":"217","author":"N Espy","year":"2018","journal-title":"J Infect Dis"},{"key":"ppat.1011948.ref010","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1099\/vir.0.81175-0","article-title":"Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virus","volume":"86","author":"AA Ahmed","year":"2005","journal-title":"J Gen Virol"},{"key":"ppat.1011948.ref011","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","article-title":"Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever","volume":"184","author":"JM Fels","year":"2021","journal-title":"Cell"},{"key":"ppat.1011948.ref012","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.abl6502","article-title":"Structural basis of synergistic neutralization of Crimean-Congo hemorrhagic fever virus by human antibodies","volume":"375","author":"AK Mishra","year":"2022","journal-title":"Science"},{"key":"ppat.1011948.ref013","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1128\/JVI.76.14.7263-7275.2002","article-title":"Characterization of the Glycoproteins of Crimean-Congo Hemorrhagic Fever Virus","volume":"76","author":"AJ Sanchez","year":"2002","journal-title":"J Virol"},{"key":"ppat.1011948.ref014","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.virs.2022.12.007","article-title":"Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo","volume":"38","author":"Q Wang","year":"2023","journal-title":"Virol Sin"},{"key":"ppat.1011948.ref015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.virs.2022.01.015","article-title":"Cryo-EM structure of glycoprotein C from Crimean-Congo hemorrhagic fever virus","volume":"37","author":"N Li","year":"2022","journal-title":"Virol Sin"},{"key":"ppat.1011948.ref016","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","article-title":"Cellular Localization and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins","volume":"79","author":"A Bertolotti-Ciarlet","year":"2005","journal-title":"J Virol"},{"key":"ppat.1011948.ref017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2017.08.014","article-title":"Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus","volume":"146","author":"M Zivcec","year":"2017","journal-title":"Antiviral Res"},{"key":"ppat.1011948.ref018","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw9535","article-title":"GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection.","volume":"5","author":"JW Golden","year":"2019","journal-title":"Sci Adv."},{"key":"ppat.1011948.ref019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"DA Bente","year":"2013","journal-title":"Antiviral Res"},{"key":"ppat.1011948.ref020","doi-asserted-by":"crossref","first-page":"8834","DOI":"10.1128\/JVI.00752-06","article-title":"Crimean-Congo Hemorrhagic Fever Virus Genomics and Global Diversity","volume":"80","author":"M Deyde Varough","year":"2006","journal-title":"J Virol"},{"key":"ppat.1011948.ref021","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1038\/s41467-022-34923-0","article-title":"Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus.","volume":"13","author":"IA Durie","year":"2022","journal-title":"Nat Commun"},{"key":"ppat.1011948.ref022","doi-asserted-by":"crossref","first-page":"e02005","DOI":"10.1128\/JVI.02005-19","article-title":"Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38","volume":"94","author":"AK Mishra","year":"2020","journal-title":"J Virol"},{"key":"ppat.1011948.ref023","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1093\/infdis\/jiy285","article-title":"Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates","volume":"218","author":"KE Pascal","year":"2018","journal-title":"J Infect Dis"},{"key":"ppat.1011948.ref024","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.aad5224","article-title":"Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody","volume":"351","author":"D Corti","year":"2016","journal-title":"Science"},{"key":"ppat.1011948.ref025","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics","volume":"381","author":"S Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"ppat.1011948.ref026","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","article-title":"Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality.","volume":"29","author":"H Li","year":"2019","journal-title":"Cell Res"},{"key":"ppat.1011948.ref027","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12250-016-3936-9","article-title":"A new strain of Crimean-Congo hemorrhagic fever virus isolated from Xinjiang, China.","volume":"32","author":"R Guo","year":"2017","journal-title":"Virol Sin"},{"key":"ppat.1011948.ref028","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00705-016-2803-1","article-title":"Analysis of the entry mechanism of Crimean-Congo hemorrhagic fever virus, using a vesicular stomatitis virus pseudotyping system.","volume":"161","author":"Y Suda","year":"2016","journal-title":"Arch of Virol."},{"key":"ppat.1011948.ref029","doi-asserted-by":"crossref","first-page":"e2104333","DOI":"10.1002\/advs.202104333","article-title":"Potent Anti-SARS-CoV-2 Efficacy of COVID-19 Hyperimmune Globulin from Vaccine-Immunized Plasma.","volume":"9","author":"D Yu","year":"2022","journal-title":"Adv Sci."},{"key":"ppat.1011948.ref030","doi-asserted-by":"crossref","first-page":"648077","DOI":"10.3389\/fcimb.2021.648077","article-title":"Differential Cell Line Susceptibility to Crimean-Congo Hemorrhagic Fever Virus.","volume":"11","author":"S Dai","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ppat.1011948.ref031","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"DN Mastronarde","year":"2005","journal-title":"J Struct Biol"},{"key":"ppat.1011948.ref032","doi-asserted-by":"crossref","first-page":"e42166","DOI":"10.7554\/eLife.42166","article-title":"New tools for automated high-resolution cryo-EM structure determination in RELION-3.","volume":"7","author":"J Zivanov","year":"2018","journal-title":"Elife."},{"key":"ppat.1011948.ref033","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"A Punjani","year":"2017","journal-title":"Nat Methods"},{"key":"ppat.1011948.ref034","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ppat.1011948.ref035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"P Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ppat.1011948.ref036","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"PD Adams","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ppat.1011948.ref037","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"VB Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ppat.1011948.ref038","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: Meeting modern challenges in visualization and analysis","volume":"27","author":"TD Goddard","year":"2018","journal-title":"Protein Sci"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1011948","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T18:32:02Z","timestamp":1707849122000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011948"}},"subtitle":[],"editor":[{"given":"Amy L.","family":"Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1011948","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1011948","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}